Aperio Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$3.58M Buy
83,719
+7,598
+10% +$273K 0.01% 978
2020
Q3
$2M Buy
76,121
+11,412
+18% +$318K 0.01% 1115
2020
Q2
$1.74M Buy
64,709
+11,245
+21% +$254K 0.01% 1171
2020
Q1
$962K Buy
53,464
+7,685
+17% +$146K ﹤0.01% 1327
2019
Q4
$812K Buy
45,779
+8,446
+23% +$146K ﹤0.01% 1550
2019
Q3
$579K Buy
37,333
+10,577
+40% +$174K ﹤0.01% 1675
2019
Q2
$460K Buy
26,756
+1,120
+4% +$18.1K ﹤0.01% 1825
2019
Q1
$413K Buy
25,636
+2,169
+9% +$35.1K ﹤0.01% 1855
2018
Q4
$343K Buy
23,467
+6,690
+40% +$107K ﹤0.01% 1884
2018
Q3
$305K Buy
16,777
+1,134
+7% +$19.9K ﹤0.01% 2003
2018
Q2
$264K Sell
15,643
-2,126
-12% -$40.2K ﹤0.01% 2053
2018
Q1
$348K Buy
17,769
+422
+2% +$8.17K ﹤0.01% 1876
2017
Q4
$351K Buy
17,347
+1,729
+11% +$31.8K ﹤0.01% 1869
2017
Q3
$271K Sell
15,618
-13,205
-46% -$179K ﹤0.01% 1972
2017
Q2
$370K Buy
28,823
+14,353
+99% +$192K ﹤0.01% 1789
2017
Q1
$188K Buy
14,470
+350
+2% +$4.42K ﹤0.01% 2053
2016
Q4
$140K Sell
14,120
-4,058
-22% -$44.4K ﹤0.01% 2055
2016
Q3
$220K Buy
18,178
+5,926
+48% +$60.6K ﹤0.01% 1893
2016
Q2
$106K Buy
+12,252
New +$121K ﹤0.01% 1958
2015
Q4
Sell
-10,566
Closed -$142K 2006
2015
Q3
$142K Buy
10,566
+1,107
+12% +$22.2K ﹤0.01% 1817
2015
Q2
$214K Buy
+9,459
New +$166K ﹤0.01% 1822

Other funds holding HALO

Aperio Group's HALO Position: Q4 2020 in Review

Aperio Group increased its Halozyme (HALO) stake by 10% in Q4 2020, buying an estimated $273K and bringing the position to 83,719 shares worth $3.58M. The position accounts for 0.01% of the portfolio, ranked #978.

Aperio Group first reported a position in HALO in Q2 2015 and has held it in 21 quarters since. 343 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

  • Aperio Group held 83,719 shares of Halozyme worth $3.58M as of Q4 2020.
  • Aperio Group bought 7,598 Halozyme shares in Q4 2020, an estimated $273K.
  • Halozyme made up 0.01% of Aperio Group's portfolio in Q4 2020, its #978 holding.
  • Aperio Group first reported a position in Halozyme in Q2 2015 and has held it in 21 quarters since.
  • 343 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.